The Bordeaux group has made major progress in the genotyping and phenotyping of hepatocellular adenomas. Their efforts have allowed the classification of hepatocellular adenomas into subtypes, which enhances our understanding of this benign liver lesion. The clinical relevance of their findings is open to debate.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rooks, J. B. et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242, 644–648 (1979).
Cobey, F. C. & Salem, R. R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am. J. Surg. 187, 181–191 (2004).
Bioulac-Sage, P., Laumonier, H., Laurent, C., Zucman-Rossi, J. & Balabaud, C. Hepatocellular adenoma: what is new in 2008. Hepatol. Int. 2, 316–321 (2008).
Bioulac-Sage, P. et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50, 481–489 (2009).
Terkivatan, T. et al. Indications and long-term outcome of treatment for benign hepatic tumours: a critical appraisal. Arch. Surg. 136, 1033–1038 (2001).
Lee, H. Y. et al. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Clin. Imaging 32, 287–295 (2008).
Terkivatan, T. & IJzermans, J. N. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J. Magn. Reson. Imaging 24, 864–872 (2006).
Atwell, T. D. et al. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am. J. Roentgenol. 184, 828–831 (2005).
Van der Sluis, F. J. et al. Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology 252, 737–746 (2009).
Van der Windt, D. J., Kok, N. F., de Man, R. A. & Ijzermans, J. N. Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences [Dutch]. Ned. Tijdschr. Geneeskd. 151, 1345–1351 (2007).
Van der Windt, D. J. et al. Case-orientated approach to the management of hepatocellular adenoma. Br. J. Surg. 93, 1495–1502 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Terkivatan, T., Ijzermans, J. Should phenotypic classification direct management?. Nat Rev Gastroenterol Hepatol 6, 697–698 (2009). https://doi.org/10.1038/nrgastro.2009.199
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.199
This article is cited by
-
Diagnosis and management of solid benign liver lesions
Nature Reviews Gastroenterology & Hepatology (2014)
